| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/12/2004 | US20040029893 Method of treatment of non-invasive mucositis |
| 02/12/2004 | US20040029891 Use of PDE5 inhibitors in the treatment of polycystic ovary syndrome |
| 02/12/2004 | US20040029877 Immune response induction; viricides; anticancer agents |
| 02/12/2004 | US20040029871 Pharmaceutical compounds for treating copd |
| 02/12/2004 | US20040029869 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 02/12/2004 | US20040029864 Synergistic mixture of cyclooxygenase inhibitor and active drug |
| 02/12/2004 | US20040029860 Anti-proliferative drugs |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029849 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/12/2004 | US20040029845 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 02/12/2004 | US20040029843 Rapidly disintegrating formulations for treating or preventing mucositis |
| 02/12/2004 | US20040029833 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 02/12/2004 | US20040029832 Anticancer agents; angiogenesis inhibitor; side effect reduction |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029779 Enzyme replacement therapy; gene therapy; preenzyme moderation of cell surface |
| 02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029180 Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 |
| 02/12/2004 | US20040029172 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040029112 Oncolytic viruses as phenotyping agents for neoplasms |
| 02/12/2004 | US20040028759 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil and sitosterol |
| 02/12/2004 | US20040028755 Use of CYP2D6 inhibitors in combination therapies |
| 02/12/2004 | US20040028753 Inhalation of nitric oxide |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | US20040028750 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028740 Transferring to cells; gene therapy; active drug in lipophilic matrix |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028732 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 02/12/2004 | US20040028707 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 02/12/2004 | US20040028706 Neuralgia pain treatment by peripheral administration of a neurotoxin |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/12/2004 | US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 02/12/2004 | US20040028672 Calibration of infection therapy measuring proteinase; antiulcer agents; wound healing agent |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028665 Compositions and methods for inhibiting pathogenic growth |
| 02/12/2004 | US20040028663 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 02/12/2004 | US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028649 Regenerating cells |
| 02/12/2004 | US20040028644 Synergistic mixture |
| 02/12/2004 | US20040028639 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 02/12/2004 | US20040028627 Mixture of hydroquinone and ascorbic compound |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028617 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction |
| 02/12/2004 | US20040028616 Dna-polyethylenimine complex; aerosol administering gene and anticancer agents |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | US20040028613 Intranasal administering; nervous system disorders |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | CA2494801A1 Medicinal composition containing hmg-coa reductase inhibitor |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494316A1 Improved injection system |
| 02/12/2004 | CA2494311A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/11/2004 | EP1388352A1 Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment |
| 02/11/2004 | EP1388351A1 Use of fibrate to treat weight gain associated with rosiglitazone treatment |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387892A2 Gene delivery compounds |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387844A1 Retinol derivatives potentiation of active substances by micellar preparation |
| 02/11/2004 | EP1387697A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21 |
| 02/11/2004 | EP1387689A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |
| 02/11/2004 | EP1387687A2 Novel use |
| 02/11/2004 | EP1387686A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection |
| 02/11/2004 | EP1387685A1 Analgesic composition and method |
| 02/11/2004 | EP1387684A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| 02/11/2004 | EP1387683A1 Novel salt and crystalline forms of (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline |
| 02/11/2004 | EP1387681A2 Antiviral compounds |
| 02/11/2004 | EP1387677A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 02/11/2004 | EP1387676A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 02/11/2004 | EP1387675A2 Liquid formulation of metformin |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1387673A1 Abuse-resistant controlled-release opioid dosage form |
| 02/11/2004 | EP1387665A2 System for delivering cosmetics and pharmaceuticals |
| 02/11/2004 | EP1289544B1 Method for treating a movement disorder |
| 02/11/2004 | EP1235569B1 Medicament and combination of compatible medicaments |
| 02/11/2004 | EP1227795B1 Lipid complex of alkycyclines |
| 02/11/2004 | EP1180944B1 Compositions containing creatine in suspension |